» News » PM to visit Serum Institute on Nov 28 to take stock of 'Covishield'

PM to visit Serum Institute on Nov 28 to take stock of 'Covishield'

Source: PTI  -  Edited By: Hemant Waje
Last updated on: November 27, 2020 03:08 IST
Get Rediff News in your Inbox:

Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and the Oxford University for COVID-19 vaccine, a senior official said on Thursday.


The Central Drug Standard Control Organisation has granted permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms, two of which are the Serum Institute of India (SII) and the Gennova Biopharmaceuticals.

"We have received a confirmation about PM Modi's visit to the Serum Institute of India on Saturday," Pune Divisional Commissioner Saurabh Rao said.

"The PM will arrive at the Pune airport at 12.30 pm on Saturday. He will attend the scheduled programme at the Serum Institute of India from 1 pm to 2 pm, where he will review the mechanism of COVID-19 vaccine production and its distribution," he said.

Ahead of the PM's visit, a Special Protection Group (SPG) team has arrived in Pune for security arrangements and the local machinery, including the police, fire brigade, departments of revenue, PWD and health, are coordinating.

On Tuesday, Rao said there was a possibility of the PM's visit to Pune, and if that happens, it would be aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanisms.

Rao had also informed that ambassadors and envoys from 100 countries will visit the Serum Institute of India and the Gennova Biopharmaceuticals Ltd in Pune on December 4.

Get Rediff News in your Inbox:
Source: PTI  -  Edited By: Hemant Waje© Copyright 2021 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
The War Against Coronavirus

The War Against Coronavirus